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Neutrophils are endowed with a plethora of toxic molecules that are mobilized in immune responses. These
cells evolved to fight infections, but when deployed at the wrong time and in the wrong place, they cause
damage to the host. Here, we review the generalities of these cells as well as the difficulties encountered
when trying to unravel them mechanistically. We then focus on how neutrophils develop and their function
in infection. We center our attention on human neutrophils and what we learn from clinical immunodefi-
ciencies. Finally, we use autoimmune disease to illustrate the harmful potential of dysregulated neutrophil
responses.Introduction
Neutrophils are the most abundant white blood cells, and defi-
ciencies in these cells, inherited or acquired, often result in
severe infections (Klein, 2011). Curiously, in spite of their obvious
relevance in immunity, in comparison to other immune cells, we
know relatively little about how they function. Neutrophils are
easy to recognize because of their uniquely lobulated nucleus,
which has earned these cells the alternative name of polymor-
phonuclear cells (PMNs), and we use these two names indistinc-
tively. They contain different types of granules packed with
molecules that allow them to fulfil their antimicrobial function.
Neutrophils develop in the bone marrow and emerge as termi-
nally differentiated cells in circulation, where they live a short
life (whether it is hours or days is currently debated) (Pillay
et al., 2010; Tak et al., 2013), unless called into action at an in-
flammatory site (Nathan, 2006; Amulic et al., 2012).
Neutrophils are recruited from the circulation to an infection
site in response to the call of microbial molecules and cytokines
produced by tissue-resident cells, like interleukin-1b (IL-1b),
IL-6, and tumor necrosis factor a (TNF-a), or chemokines, like
IL-8. Neutrophils are the first cells to arrive at an inflammatory
site, and they do that in massive numbers. T cells and other
immune cells also recruit neutrophils duringmore chronic inflam-
mation, for example by secreting IL-17. Regardless of the cue,
neutrophils in circulation first recognize signals in the endothe-
lium close to an inflammatory site and, after rolling on the endo-
thelium, extravasate into the tissue in a process that has been
well described and reviewed (Borregaard, 2010; Kolaczkowska
and Kubes, 2013). Once entered into tissues, neutrophils are fully
equipped to fight infections and to interact with other cells of the
immune system.
When a neutrophil meets a microbe, it can respond through
various mechanisms, and here we will concentrate on degranu-
lation, phagocytosis, or the generation of neutrophil extracellular
traps (NETs). Microbes might also trigger other mechanisms,
like autophagy, apoptosis, or pyroptosis, which we will not
review here because of space limitations. Degranulation is an
exocytosis process, whereby neutrophil granules fuse with the
cytoplasmic membrane, releasing an arsenal of enzymes, anti-
microbial peptides, and other molecules into the surrounding tis-
sue. These include proteases that degrade virulence factors and
toxins, lysozyme that degrades the bacterial cell wall, and526 Cell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc.antimicrobials like bactericidal/permeability-increasing protein
(BPI), cathelicidins, and defensins that can kill bacteria directly,
at least at high concentrations and in buffer solutions in vitro.
Once released, these molecules have powerful antimicrobial
capacities, but they also harm the host tissue by collateral dam-
age. During phagocytosis, microbes or other particles are recog-
nized by pattern recognition receptors (PRRs) or, even more
efficiently, by antibody or complement receptors if the particles
are opsonised. When recognized, particles are first engulfed in
a phagosome, which later fuses with granules to make a phago-
lysosome. In this process, the NADPH oxidase is assembled
to convert oxygen into oxidizing molecules like superoxide,
hydrogen peroxide, and halic acids, collectively called reactive
oxygen species (ROS). The combination of granule contents
and ROS leads to an efficient killing of microbes, and it is likely
that these processes act in concert and potentiate each other.
Besides phagocytosis and degranulation, neutrophils stimulated
by microbes or by specific antibodies can also undergo an un-
usual form of cell death where chromatin gets processed,
studded with antimicrobial proteins, and released in the form
of NETs. Indeed, the extrusion of chromatin likely occurs through
different mechanisms, including the fascinating nuclear exclu-
sion recently described (Yipp et al., 2012). NETs expose a
concentrated form of antimicrobials, including histones, which
can trap and kill microbes as well as activate other immune cells.
Neutrophils might be triggered to respond differently to distinct
microbes, and the relevance of these antimicrobial processes
in specific diseases is not entirely clear.
The occurrence of life-threatening infections in neutropenic
patients illustrates the importance of neutrophils in antimicrobial
defense. In addition, several rare immune deficiencies have been
described as affecting particular antimicrobial functions of neu-
trophils (Bouma et al., 2010). Patients with such deficiencies
often suffer from infections caused by opportunistic pathogens
that rarely cause severe infections in healthy individuals. These
‘‘experiments of nature’’ show that neutrophils are crucial cells
in host defense against microbes. The specific phenotypes of
these patients can help us understand neutrophil function.
Traditionally, based on their impressive antimicrobial capacity
in vitro and the susceptibility of patients with few or defective
neutrophils, we think of PMNs primarily as microbe hunters.
This viewmight well be correct, but in the last decade neutrophils
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cells like dendritic cells (DCs), macrophages, natural killer (NK)
cells, B cells, and T cells. These advances were recently re-
viewed (Mo´csai, 2013), and we will only touch upon them in
the context of neutrophils as the culprit of jumpstarting autoim-
munity after infections. Due to these diverse functions, on top
of the collateral damage occurring during their antimicrobial
action, neutrophils are now implicated in many diseases, includ-
ing cancer, metabolic diseases, and circulatory disturbances.
In this review, we will examine the mechanism of neutrophil
development, the role of neutrophils in infections (with a focus
on immunodeficiency), and how neutrophil activation can also
be detrimental to the host, as demonstrated by their involvement
in the development of autoimmunity. However, before proceed-
ing, a few cautionary words are necessary. Neutrophils are short
lived, do not divide, and cannot be genetically modified. There
are few neutrophil cell lines, and mice are an imperfect model
organism since they do not fully mimic human neutrophils in
function, morphology, or physiology. In vivo, murine neutrophils
can be depleted with antibodies, but this depletion is transient,
as low neutrophil numbers trigger the production of new
PMNs. On the positive side, neutrophils are abundant in human
blood, and it is relatively easy to obtain populations allowing
short-term experiments. The limitations in interpreting results
with human neutrophils are that, since the experiments can be
performed only in vitro, the cells rest on artificial substrates
andmedia. Thus, it might be important to consider these caveats
while reading this review.
Development of Neutrophils
The Development of Granulocyte Precursors
Neutrophils that leave the bone marrow and enter the blood-
stream are terminally differentiated cells with a short lifespan.
To maintain a stable number of neutrophils in circulation, they
are produced at the staggering rate of 1 3 1011–2 3 1011 per
day in humans. The development of granulocyte precursors as
well as the terminal differentiation of neutrophils are complex
processes that are controlled by transcriptional regulation,
growth factors, cytokines, microRNAs, and other regulatory sys-
tems. Understanding hematopoietic development necessitates
the use of mice; in this section, we deviate from a clinical
perspective and report mainly the work of many colleagues in
experimental animals.
The initial precursors of neutrophils are hematopoietic stem
cells (HSCs), which reside in low numbers in bonemarrow niches
(Figure 1). These slowly dividing cells are capable of self-renewal
and are maintained in these niches by interacting with stromal
cells such as osteoblasts (Orkin and Zon, 2008). In the first
step of their development, HSCs lose their self-renewing poten-
tial and give rise to multipotent precursors (MPPs) that can
develop into all blood cell lineages. Several models have been
proposed about the lineage choice of MPPs. It is currently
assumed that MPPs develop into either lymphomyeloid or eryth-
romyeloid progenitors (Go¨rgens et al., 2013a). Interestingly, neu-
trophils arise from the lymphomyeloid progenitors, whereas the
other granulocyte subtypes, eosinophils and basophils, are
generated from the erythromyeloid lineage (Go¨rgens et al.,
2013b). The decision of MPPs to undergo differentiation into
either the lymphomyeloid or the erythromyeloid direction de-pends largely on the balance between the transcription factors
GATA-1 and PU.1. These factors antagonize each other, and
high levels of PU.1 are crucial to generate the lymphomyeloid
lineage (Arinobu et al., 2007; McKercher et al., 1996).
Lymphomyeloid precursors can give rise to granulocyte/
monocyte precursors (GMPs), a decision tightly controlled by
the transcription factor family of CCAAT enhancer-binding pro-
teins (C/EBP). C/EBP-a is absolutely required for neutrophil
development, regulating expression of proteins necessary for
neutrophil differentiation such as granulocyte colony-stimulating
factor receptor (G-CSFR) (Radomska et al., 1998). Indeed,
G-CSF is the most important cytokine during neutrophil differen-
tiation, although a minor amount of functional neutrophils can
still be generated in the absence of this growth factor (Lieschke
et al., 1994; Zhang et al., 1997).
Neutrophil Terminal Differentiation
Neutrophil precursors first develop into a myeloblast, a relatively
small (10 mm) cell that does not express granule proteins. Myelo-
blasts give rise to promyelocytes, which further differentiate into
myelocytes, metamyelocytes, band cells (which are generally
considered immature immune cells), and finally segmented neu-
trophils, which are then able to leave the bone marrow and enter
the bloodstream (Bainton et al., 1971) (Figure 1). After the pro-
myelocyte stage, the differentiating neutrophils exit the cell
cycle. Granules are formed continuously during the differentia-
tion process from the promyelocyte stage onward. Primary (or
azurophilic) granules are made in promyelocytes, secondary
(or specific) granules in myelocytes, tertiary (or gelatinase) gran-
ules in band cells, and secretory vesicles in segmented neutro-
phils (Borregaard, 2010). Proteins do not carry a specific signal
sequence targeting them as granule cargo. Therefore, the con-
tent of a granule most likely reflects the gene expression pattern
of the differentiation stage during which the granule was formed.
This unspecific loading also suggests that the classification into
distinct granule subtypes may not be absolute and there might
be granules containing proteins of different subtypes.
Similarly to the development of granulocyte precursors, termi-
nal differentiation of neutrophils is regulated by a balance be-
tween different transcription factors. C/EBP-a, as well as Gfi-1
or Lef-1, is abundant in myeloblasts, but its expression de-
creases as differentiation progresses (Bjerregaard et al., 2003).
In contrast, C/EBP-ε peaks during the myelocyte/metamyelo-
cyte stages, and the expression of C/EBP-b, C/EBP-g, and
C/EBP-d continuously increases during neutrophil maturation
(Bjerregaard et al., 2003). Interestingly, as described below, in-
fections or inflammation triggers granulopoiesis, which depends
on transcription factors different from those depended upon in
homeostatic conditions.
Although transcriptional regulation is essential for neutrophil
terminal differentiation, other regulatory mechanisms also influ-
ence the process. For example, it has been shown that some
neutrophil mRNAs are able to retain their introns by a poorly
characterized mode of alternative splicing called intron retention
(IR), a phenomenon that increases during differentiation (Wong
et al., 2013). These retained introns might result in premature
stop codons, and the mRNAs could therefore be targeted for
degradation by the cell’s nonsense-mediated mRNA decay
machinery. Indeed, several gene products seem to be down-
regulated through an IR-dependent mechanism during theCell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc. 527
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Figure 1. The Development of Neutrophils from Hematopoietic Stem Cells
Precursor development and terminal differentiation of neutrophils from hematopoietic stem cells. Essential transcription factors are highlighted in pink. HSC,
hematopoietic stem cell; MPP, multipotent precursor; EMP, erythromyeloid precursor; LMP, lymphomyeloid precursor; GMP, granulocyte-macrophage pre-
cursor. Please refer to the Development of Neutrophils section for details. Adapted from Borregaard (2010).
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(Lmnb1), which regulates nuclear morphology. Interestingly,
expression of a nondegradable mutant of Lmnb1, containing
no introns, results in an aberrant differentiation and the alteration
of the characteristic shape of the neutrophil nucleus (Wong et al.,
2013).
Neutrophil Development during Homeostasis and
Infections
Neutrophils are highly efficient when it comes to killing microor-
ganisms. However, their modes of action are rather unspecific
and capable of harming the host as well as the invading path-
ogen, a recurrent theme in this review. It therefore makes sense
that both the production and release of neutrophils from the
bonemarrow are tightly regulated. Indeed, the amount of neutro-
phils in peripheral tissues influences the production rate of new
precursors in the bone marrow through a negative feedback
loop. Neutrophils of mice deficient for adhesion molecules are
not able to pass the endothelium. The resulting low level of neu-
trophils in peripheral tissues triggers tissue-resident macro-
phages and DCs to produce IL-23. IL-23 induces T helper 17
(Th17) cells to make IL-17, leading to G-CSF expression, which
enhances neutrophil differentiation (Stark et al., 2005). In wild-528 Cell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc.type animals, neutrophils are abundant in peripheral tissues,
where they regularly undergo apoptosis. It has been suggested
that the clearance of apoptotic neutrophils by macrophages
and DCs blunts the production of IL-23 and is therefore one of
several possible pathways by which to regulate granulopoiesis
(Stark et al., 2005). However, mice deficient for T cells, B cells,
and NK cells can still produce enhanced G-CSF and increase
granulopoiesis in response to neutrophil depletion, indicating
that neutrophil development is occurring in the absence of
T cell-produced IL-17. Granulopoiesis is most likely regulated
by various and possibly redundant mechanisms (Bugl et al.,
2012, 2013). Furthermore, a recent study showed that ‘‘old’’ neu-
trophils in circulation return to the bone marrow, where they are
phagocytosed by resident macrophages. In turn, macrophages
stimulate the release of new progenitors to maintain the number
of neutrophils in circulation. Interestingly, this cycle of neutrophil
release and clearance oscillates in circadian rhythms, with aged
neutrophils being cleared from the circulation at the end of the
resting period of mice (Casanova-Acebes et al., 2013).
The production of neutrophils is even further enhanced during
infections by a process called emergency granulopoiesis.
When neutrophils combating pathogenic microorganisms die
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lopoiesis, thus satisfying the organism’s cellular requirement to
combat infections. Notably, and similarly to homeostasis, emer-
gency granulopoiesis depends on C/EBP transcription factors;
however, during emergency, C/EBP-b seems to be the driving
force behind granulopoiesis, whereas C/EBP-a is dispensable
(Hirai et al., 2006). However, C/EBP-b is required for terminal dif-
ferentiation rather than for precursor development (Cain et al.,
2011). Surprisingly, although G-CSF is a major regulator of
homeostatic neutrophil development, it is not necessary for an
emergency response to infection with the fungal pathogen
Candida albicans (Basu et al., 2000). Conversely, other reports
demonstrated that G-CSF is crucial for emergency granulopoie-
sis, for example during infections with the intracellular bacteria
Listeria monocytogenes. The role of G-CSF in emergency gran-
ulopoiesis therefore seems to be context dependent, and there
could be other cytokines regulating neutrophil development in
the absence of G-CSF (Panopoulos and Watowich, 2008).
G-CSF can be induced by an inflammatory milieu, which leads
tomobilization of neutrophils from the bonemarrow. The ensuing
neutropenia in the bone marrow triggers the production of new
precursors (Cain et al., 2011). This suggests that granulopoiesis
is influenced not only by the previously mentioned abundance of
neutrophils in peripheral tissues, but also by neutrophil density in
the bone marrow.
Surprisingly, germ-free mice are severely neutropenic, to a
higher extent than G-CSF- or G-CSFR-deficient animals, sug-
gesting that microflora also regulate granulopoiesis (Bugl
et al., 2013). Neutrophil depletion leads to an increased produc-
tion of G-CSF and subsequent neutrophil development. How-
ever, this response is abolished in animals deficient for the
PRR Toll-like receptor 4 (TLR4) or its adaptor TRIF, indicating
that TLR4 ligands provided by the microflora induce granulo-
poiesis (Bugl et al., 2013). These ligands could also be pro-
vided by invading pathogens, and therefore the TLR4-TRIF
axis might be a common regulator of homeostatic and emer-
gency granulopoiesis.
The observation that hematopoietic stem and progenitor cells
(HSPCs) are able to migrate from the bone marrow to skin
wounds, where they differentiate into mature neutrophils and
exert their defense functions, added further complexity to the
regulation of granulopoiesis (Granick et al., 2013). The number
of HSPCs migrating to the site of injury was markedly enhanced
in the context of Staphylococcus aureus-infected skin wounds
and depended on the expression of TLR2 and its adaptor
MyD88 in HSPCs. The induction of TLR2/MyD88 signaling
resulted in production of prostaglandin E2 in HSPCs, thereby
supporting their survival and proliferation (Granick et al., 2013).
Differentiation of functional neutrophils can therefore occur at
sites of infection, possibly helping establish localized responses
against pathogens.
It is clear that neutrophil development is dynamic and regu-
lated by a variety of factors, such as genetic background, cyto-
kine milieu, or the amount of neutrophils present in peripheral
blood or tissues, that influence each other. Furthermore, inflam-
mation or infections are able to trigger enhanced granulopoiesis
in order to fulfil the organism’s need for an increase in the number
of immune cells. The mechanisms of homeostatic and emer-
gency granulopoiesis have been extensively studied, but thereare still open questions, especially regarding how the two pro-
cesses are linked and where they differ from each other.
Neutrophils in Infection
As outlined above, neutrophils are the first line of host defense
against pathogens, as they are recruited in great numbers to
the site of infection. Therefore, the absence of neutrophils or
impairment of neutrophil activation can lead to severe infections.
Themost common pathogen in patients with neutropenia or spe-
cific neutrophil function disorders is S. aureus (Winkelstein et al.,
2000; Picard et al., 2010). Fungi like Candida and Aspergillus
species also cause frequent problems when one or all of the
neutrophil antimicrobial defense systems are impaired (Smeek-
ens et al., 2013). Microbes evolved virulence factors to avoid
or target the neutrophil, as illustrated by the extensive arsenal
that S. aureus acquired against this host immune cell (Spaan
et al., 2013). S. aureus blocks neutrophil activation, PRR recog-
nition, and produces a golden pigment with antioxidant proper-
ties to protect itself against ROS damage within the phagosome
(Liu et al., 2005). Although S. aureus neutralizes almost all
weapons of neutrophils, healthy individuals can deal with this
bacterium quite efficiently. In this section, we will focus on immu-
nodeficiencies that affect the microbial recognition and antimi-
crobial functions of neutrophils.
Microbial Recognition
TLRs recognize a variety of highly conserved microbial ligands
that are usually essential for microbial fitness. Human neutro-
phils express almost all TLRs, except TLR3 and TLR7 (Janke
et al., 2009). They also recognize microbial ligands via C-type
lectins and sense intracellular microbial danger signals via the in-
flammasome. TLRs and C-type lectins trigger neutrophil migra-
tion, phagocytosis, programmed cell death, ROS generation,
and cytokine production. Upon TLR activation, the intracellular
receptor domain recruits adaptor proteins like MyD88. MyD88
recruits interleukin-1 receptor-associated kinase (IRAK) com-
plex, including the two kinases IRAK1 and IRAK4. Activated
IRAK1 initiates further downstream signaling, leading to phos-
phorylation of the inhibitor of kB (IkB) by the IkB kinase complex
(IKK) and release of NF-kB. The IKK complex consists of
three subunits: IKK-a, IKK-b, and NF-kB essential modulator
(NEMO). NF-kB induces expression of different inflammatory
genes that trigger further neutrophil activation and secretion of
proinflammatory cytokines. In contrast to other cells, neutrophils
signal only via the MyD88 pathway and not via TRIF (Tamassia
et al., 2007). TLR3 and TLR4 activate this MyD88-independent
pathway in other cells; however, TRIF signaling is not induced
upon TLR4 ligation in neutrophils.
A deficiency in IRAK4was found in patients with recurrent pyo-
genic infections (Picard et al., 2010). These individuals were
mostly suffering from Streptococcus pyogenes, Pseudomonas
aeruginosa, and S. aureus infections, whereas they had normal
resistance against many other bacteria and fungi. Neutrophils
isolated from these patients fail to produce an oxidative burst
in response to different TLR ligands. Another study, which
included a single IRAK4-deficient patient, showed that these
neutrophils also fail to respond to TLR ligands, but killing of
bacteria and fungi was unaffected (van Bruggen et al., 2010).
This suggests that recognition of microbial ligands is redundant
in neutrophils or that some bacteria developed strategies toCell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc. 529
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Figure 2. Schematic Overview of ROS Production in the Phagosome
MPO is stored in azurophilic granules within the neutrophil. After phagocytosis,
the granules fuse and release MPO into the phagosome. The NADPH oxidase
complex generates superoxide that is converted into hydrogen peroxide.MPO
uses hydrogen peroxide to catalyze the production of potent antimicrobial
molecules, such as hypochlorous acid.
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suffer from bacterial infections similar to those of IRAK4-defi-
cient individuals (von Bernuth et al., 2008). Invasive infections
in IRAK4- and MyD88-deficient individuals have a 30%mortality
rate in infants. The susceptibility to infections decreases with
age, suggesting that other parts of the immune system take
over later in life.
Analogous effects were observed in neutrophils from patients
with a mutation in NEMO (Singh et al., 2009). However, NEMO-
deficient patients suffer from infections with a broader range of
microbes, as seen in MyD88 and IRAK4 deficiencies. This prob-
ably reflects the involvement of NEMO in regulation of other
pathways that activate NF-kB, such as the T cell receptor and
TNF receptor family (Picard et al., 2011).
A recent study reported a link between caspase recruitment
domain-containing protein 9 (CARD9) deficiency and Candida
infections (Drewniak et al., 2013). CARD9 deficiency was identi-
fied previously in a family with a history of Candida infections.
Dectin-1 recognizes various beta-glucans from plants and fungi,
including Candida lectins, and activates downstream signaling
via a CARD9-containing complex to NF-kB. Neutrophils isolated
from a CARD9-deficient patient suffering from chronic invasive
Candida infection of the brain showed an impaired killing of non-
opsonized Candida. Nonopsonized Candida is especially rele-
vant in brain infections, since complement proteins are absent
in this part of the body. In addition, CARD9-deficient neutrophils
stimulated with C. albicans form abnormal phagolysosomes.
Neutrophils from patients with deficiencies in microbial recogni-
tion pathways clearly show impaired detection and killing of
microbes. Nevertheless, these deficiencies affect a wide variety
of cells that use these signaling pathways, and infections
observed in these patients are not necessarily caused by defects
in the antimicrobial response of neutrophils.
Reactive Oxygen Species
Neutrophils phagocytose microbes and subsequently kill them
by generating ROS within the hostile environment of the phago-
lysosome. The NADPH oxidase complex initiates the oxidative530 Cell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc.burst by converting oxygen into superoxide, which dismutates,
with the help of superoxide dismutases, to hydrogen peroxide
(Figure 2). Hydrogen peroxide, in turn, is used by myeloperoxi-
dase (MPO) to form more toxic ROS. Chronic granulomatous
disease (CGD) patients have a strongly reduced NADPH oxidase
activity due to a genetic defect in one of the components that
forms the NADPH complex (Kuhns et al., 2010). They suffer
from life-threatening infections and need chronic antibiotic or
antifungal therapy to fight microbes. Other characteristics of
CGD patients are the formation of granulomas and development
of a variety of inflammatory diseases, such as inflammatory
bowel disease.
S. aureus often causes diseases in CGD patients (around 30%
of all infections), followed by Aspergillus, Salmonella, Candida,
and Serratia species (Winkelstein et al., 2000; van den Berg
et al., 2009). The localization and outcome of the infections differ
depending on the infecting microbe: Aspergillus species mostly
cause infections in the lungs and brain with a high mortality rate.
The disease severity depends on the residual activity of the
NADPH complex, which in CGD patients can be reduced to
0.1% of its activity in healthy individuals (Kuhns et al., 2010).
Neutrophils of CGD patients show normal antimicrobial activity
when hydrogen peroxide is introduced exogenously, indicating
that CGD neutrophils function normally, except for superoxide
production.
In contrast toS. aureus, infectionswith the fungusAspergiullus
nidulans are less common in neutropenic patients (Henriet et al.,
2011). Interestingly, CGD patients suffer from severe infections
with this fungus. An obvious explanation would be that a defect
in the NADPH oxidase-mediated oxidative burst protects
A. nidulans from neutrophil-mediated killing. However, neutro-
phils maintain their antifungal activity to A. nidulans upon
chemical inhibition of the oxidative burst (Henriet et al., 2012).
Neutrophils from CGD patients showed a delayed recruitment
to the site of infection, suggesting an intact antimicrobial function
of the neutrophil itself. However, the oxidative burst also triggers
the formation of NETs, and indeed neutrophils isolated from
CGD patients fail to expel their DNA and to reduce A. nidulans
growth. Repairing the NADPH oxidase function by gene therapy
restored NET formation and the ability to prevent A. nidulans
growth and allowed the patient to clear the infection (Bianchi
et al., 2009). Monocytes and macrophages, like neutrophils,
phagocytose and degrade bacteria in their phagolysosome. A
functional NADPH oxidase also contributes to bacterial killing
in these cells. Indeed, monocytes and macrophages isolated
from CGD patients also have an impaired NADPH oxidase activ-
ity, and these cells should also be considered when studying in-
fections in CGD patients. In summary, it is likely that the NADPH
oxidase regulates several pathways, including the production of
cytokines, and these diverse functions contribute to CGD.
Subsequent to phagocytosis, azurophilic granules fuse with
and release MPO into the phagosome, which generates hypo-
chlorous acid out of hydrogen peroxide and chloride (Figure 2).
Hypochlorous acid has powerful antimicrobial activity in vitro,
suggesting that MPO plays an important role in the antimicrobial
defense of neutrophils (Klebanoff et al., 2013). Screening of neu-
trophils for MPO activity revealed that a functional deficiency in
MPO activity occurs in 1 out of 3,000 individuals (Parry et al.,
1981; Kutter, 1998). Several mutations in the gene encoding for
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or trafficking, leading to variations in residual MPO activity
among these patients, which may influence the risk for severe
infection. Some people with a MPO deficiency suffer from
Candida infections; however, most of them are apparently
healthy.
Surprisingly, despite the lack of infections in most patients,
MPO-deficient neutrophils have a clearly reduced antimicrobial
activity. Neutrophils isolated from MPO-deficient patients show
delayed and reduced killing of S. aureus and C. albicans.
Patients with MPO deficiencies have a very mild phenotype
compared to CGD patients. This is striking, since MPO is the
most abundant protein produced by neutrophils; a significant
portion of the cell’s protein content consists of MPO, and the
enzyme directly acts downstream of NADPH oxidase (Winter-
bourn et al., 2006). A difference between MPO deficiency and
CGD patients is that neutrophils and monocytes are the main
producers of MPO, whereas NADPH oxidase plays an important
role in other phagocytes. In addition, hydrogen peroxide serves
different purposes aside from the generation of hypocholorous
acid by MPO.
Antimicrobial Proteins
Neutrophils utilize antimicrobial molecules such asMPO, neutro-
phil elastase (NE), cathepsin G, and defensins to combat infec-
tion. However, although most of these proteins have clear
antimicrobial effects in vitro, their biological relevance in control-
ling infections is less clear. A mutation in the transcription factor
C/EBP-ε, essential for neutrophil differentiation, causes the rare
neutrophil-specific granule deficiency (SGD) (Shiohara et al.,
2004). Neutrophils from SGD patients have morphological ab-
normalities and functional defects. They lack primary, second-
ary, and tertiary granule proteins, including defensins and BPI,
but are sufficient in MPO and NADPH oxidase activity. These
patients suffer from infections with S. aureus, P. aeruginosa,
and Klebsiella pneumonia. However, the mutation also affects
monocytes and macrophages, and therefore infections in these
patients cannot exclusively be linked to the absence of neutro-
phil granule proteins.
The azurophilic granule protein NE cleaves a wide variety of
proteins including bacterial virulence factors (Weinrauch et al.,
2002). Activation of the serine proteases NE and cathepsin G re-
quires cleavage of the N-terminal dipeptide by dipeptidyl pepti-
dase 1 (DPPI) (Korkmaz et al., 2010). Loss-of-function mutations
in the gene encoding DPPI have been strongly associated with
the Papillon-Lefe`vre Syndrome (PLS), in which patients suffer
from skin problems and severe periodontitis. Neutrophils iso-
lated from PLS patients lack NE and cathepsin G activity and
display a reduction in phagocytic and chemotactic capacity; still,
DPPI might have other undiscovered substrates beyond NE and
cathepsin G that are important for the phenotype of PLS pa-
tients. The absence of activity of another protease in PLS neutro-
phils, proteinase-3 (PR3), results in a decreased level of the
antimicrobial peptide LL-37 (de Haar et al., 2006). PR3 normally
processes this protein into its active form. Neutrophils from PLS
patients have a reduced killing activity against the periodontic
pathogen Actinobacillus actinomycetemcomitans, which causes
periodontitis and loss of teeth in PLS patients, and the lack of
active neutrophil serine proteases may contribute to the inability
of neutrophils to clear the infection. Another study showed thatneutrophils isolated from PLS patients kill E. coli and S. aureus
as effectively as control neutrophils (Pham et al., 2004). This sug-
gests that serine proteases don’t play a crucial role in the neutro-
phil defense mechanisms against these microbes.
Antimicrobial effects of NE are mainly based on in vitro data
and infection models in mice showing that NE and cathepsin G
protect against Gram-positive, Gram-negative, and fungal infec-
tions. Humans with NE mutations suffer from severe infections;
however, this is not directly linked to NE activity. Mutations in
NE cause half of the cases of severe congenital neutropenia, a
disease characterized by a low number of circulating neutrophils
(Bouma et al., 2010). There is no link between a particular muta-
tion in the gene encoding NE and the clinical outcome, except for
one mutation that is in proximity of the NE active site and likely
alters the biological activity of the enzyme. Individuals with this
mutation have a severe form of the disease, with neutrophil
counts close to zero. The mechanism by which defects in NE
cause a decrease in the neutrophil number is still under investi-
gation. A role for the unfolded protein response, which is acti-
vated by misfolded proteins in the endoplasmic reticulum (ER),
has been proposed, leading to apoptosis (Grenda et al., 2007).
Several mutations in NE lead to improper trafficking of the pro-
tein, which may cause the accumulation of the misfolded protein
in the ER.
Genetic diseases that impair neutrophil function have a low
prevalence of less than 1 in 200,000 individuals, underscoring
the relevance of neutrophils in defense. An exception is MPO
deficiency, with a higher prevalence and relatively minor defects
in antimicrobial defense. It is important to note that the type of
infections that patients with neutrophil-affecting immunodefi-
ciency are susceptible to might be biased by the low incidence
of these inherited diseases and by the fact that many of them
live in areas with high hygienic standards. In addition, genetic
defects associated with neutrophil antimicrobial function some-
times also affect other cell types of the immune system. Never-
theless, it is clear that individuals with neutrophil functional
defects or neutropenia are more prone to infections. Microbes
causing such infections may benefit from inactivation of specific
neutrophil functions. However, infections with certain microbes
may also be a result of exposure. For instance, many people
carry S. aureus in the nose, whereas the chance of exposure to
other microbes is much lower. Interestingly, viral infections in
patients with impaired neutrophil function are not often reported.
Although studies indicate that neutrophils participate in clearing
viral infections (Gabriel et al., 2013), this may be because neutro-
phils play a minor role in the defense against viral infections or
because patients with neutrophil immunodeficiencies are rarely
exposed to viruses. Collectively, the valuable data supplied by
immunodeficiency in patients, mice, and in vitro studies have re-
vealed several potential additional antimicrobial pathways and
molecules of neutrophils.
Neutrophils in Autoimmunity
Autoimmunity is characterized as a failure to distinguish self mol-
ecules from nonself molecules. The immune response initiated
by this self-recognition results in major organ and tissue damage
(Ne´meth andMo´csai, 2012). A breakdown in themechanism that
ensures tolerance of cells to self molecules is responsible for the
initiation of autoimmunity. Tolerance is the process by whichCell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc. 531
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molecules, thus ensuring that the immune system is not acti-
vated. A break in tolerance, which is often linked to infection
(as reviewed by Bach, 2005), leads to the appearance of
autoreactive T cells that are responsible for the first wave or
‘‘immunization phase’’ of self-recognition. Upon activation of
the autoreactive T cells, a secondary immune response is initi-
ated involving many other immune cells, such as B cells, NK
cells, and neutrophils. This secondary response or ‘‘effector
phase’’ can be instigated by the autoreactive T cells in several
ways, including cytokine production or direct cell-cell contact.
A signature of autoimmunity is the generation of autoanti-
bodies that can be directed against nuclear material such as
dsDNA, ribonucleoproteins, and histones. A question of great
interest in the field of autoimmunity is the source of these self
molecules that activate autoreactive cells and lead to an adverse
immune response. Until recently, the debate centered on
whether apoptotic or necrotic cell debris were the source of
this self material that activated the immune system. However,
in the last decade a new potential source of self molecules has
come to light with the discovery of NETs. Indeed, molecules
released during NETosis are found as autoantigens in many
autoimmune diseases, including rheumatoid arthritis, systemic
lupus erythematosus, and vasculitis.
Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a prototypical autoimmune disease
that affects between 0.5%and 1%of the population in the devel-
oped world. Both genetic and environmental factors influence
the onset of RA, which is characterized by the chronic swelling
and destruction of distal synovial and larger joints. Arthritic joints
exhibit increased synovial fluid volume, high concentrations of
proinflammatory cytokines, and large cellular infiltrates that
include DCs, neutrophils, and macrophages (Ne´meth and Mo´c-
sai, 2012). RA is routinely diagnosed based on the presence of
rheumatoid factor, an autoantibody generated against the Fc
portion of immunoglobulins, and anti-citrullinated protein anti-
bodies (ACPAs) (Bugatti et al., 2007; De Rycke et al., 2004).
Neutrophils are the most abundant cell type found in the syno-
vial fluid. They also accumulate in the arthritic joints, where most
of the tissue damage occurs (Mohr et al., 1981). Animal models
of autoantibody-induced arthritis showed that neutrophils
migrate to affected areas early in disease progression (Nandaku-
mar et al., 2003; Wipke and Allen, 2001), where they produce
enhanced oxidative responses to several stimuli (Dularay et al.,
1988) and are, at least partially, responsible for the progression
and severity of the disease. Several studies looking at cell
recruitment to arthritic/inflamed joints in mice have revealed a
signaling cascade initiated by the complement C5a receptor
and Fcg receptors, resulting in the release of the inflammatory
mediator leukotriene B4 (LTB4) and IL-1b into the joint and sub-
sequent neutrophil recruitment (Kim et al., 2006; Chou et al.,
2010; Sadik et al., 2012).
Recently, it was proposed that neutrophils undergoing
NETosis may also be the source of self antigens, such as ACPAs,
that give rise to autoantibodies in RA (Khandpur et al., 2013).
Consistent with this hypothesis, five known proteins released
by NETs are considered autoantigens in RA (Darrah and An-
drade, 2012), and neutrophils isolated from RA patients have
been shown to exhibit enhanced NETosis (Khandpur et al.,532 Cell Host & Microbe 15, May 14, 2014 ª2014 Elsevier Inc.2013). Analysis of NET components identified citrullinated
vimentin, an important RA autoantigen that decorated NETs
(Khandpur et al., 2013). Independently, Pratesi et al. (2013)
demonstrated that RA patients generated antibodies against his-
tone H4 and that the source of this citrullinated protein was NETs
(Pratesi et al., 2013).
Peptidylarginine deiminase 4 (PAD4) citrullinates proteins dur-
ing RA progression. PAD4, which is expressed by neutrophils,
catalyzes the posttranslational conversion of peptidylarginine
to citrulline on histones by deimination. This process is crucial
for the generation of NETs (Wang et al., 2009). However, there
is also a detrimental side to PAD4 activation, as RA patients
have an abundance of ACPAs in their serum contributing to dis-
ease. Genetic studies show that RA patients with alleles linked to
increased RA susceptibility have more stable PAD4 mRNA and
as such may enhance PAD4 expression (Suzuki et al., 2003).
Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a prototypical autoim-
mune disease that affects around 0.1% of the world’s popula-
tion. Development of SLE results in multiorgan damage defined
by a relapsing and remitting progression. Both genetic and envi-
ronmental factors contribute to SLE development, which is char-
acterized by the dysregulated activation of T and B lymphocytes
and the production of autoantibodies directed against dsDNA,
histones, and nucleosomes. In addition, higher levels of antineu-
trophil cytoplasmic antibodies (ANCA) directed against MPO,
NE, and cathepsin G have been found in the serum of SLE
patients compared with healthy control serum (Na¨ssberger
et al., 1990; Zhao et al., 1998). These antigens and their autoan-
tibodies form immune complexes that are deposited in tissues,
including the kidneys, skin, and joints. These immune complexes
are also highly inflammatory and induce the production of IFN-a
by plasmacytoid dendritic cells (Kaplan, 2011).
Neutrophils isolated from SLE patients display abnormalities,
including increased aggregation, impaired phagocytosis, and
an increased propensity to undergo NETosis. There is also a
marked reduction in NET clearance, and as such, NETsmay pro-
vide another mechanism by which DC activation occurs. Periph-
eral blood mononuclear cells (PBMCs) isolated from adult and
pediatric SLE patients contain a subset of neutrophils that
migrate at a lower density, which are appropriately called low-
density granulocytes (LDGs) (Hacbarth and Kajdacsy-Balla,
1986). LDGs produce levels of proinflammatory cytokines higher
than those of healthy donor controls or normal SLE neutrophils
(Denny et al., 2010). These cells also form NETs more readily
than healthy donors or even SLE neutrophils and thus release
more neutrophil proteins and enzymes (Villanueva et al., 2011).
Thus, molecules released from the NETs of SLE neutrophils or
LDGs may be the source of autoantigens in SLE. Indeed, to
date, at least eight neutrophil-derived molecules that are
released upon NETosis, such as DNA, LL-37, or ribonucleopro-
teins, have been linked to SLE development (Darrah and
Andrade, 2012).
A lack of NET degradation has also been linked to SLE. DNase
I is a component of serum, and a Japanese study linked familial
SLE progression to a heterozygous nonsense mutation in exon 2
of DNase I. This mutation led to lower DNase I enzymatic activity
in the sera and B cells of these patients when comparedwith SLE
patients without the mutation and healthy controls. The levels of
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Figure 3. The Good and Bad Sides of
Neutrophil Activation
The three main antimicrobial functions of neutro-
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aspects for the host.
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greatly increased in these DNase I mutant patients (Yasutomo
et al., 2001). A subsequent investigation in pediatric SLE patients
demonstrated that a mutation in the DNase I homolog DNase IL3
was also linked to SLE development (Al-Mayouf et al., 2011).
These studies reveal that a lack of functioning DNase I is found
in SLE patients. Alternatively, a decrease in DNase I activity in
SLE patients can also occur due to the presence of antibodies
against DNase I or NETs (Hakkim et al., 2010). The inability of
DNase I to degrade NETs correlated with the development of
severe glomerulonephritis.
Vasculitis
Vasculitis is the broad term used for a group of diseases that
affect the blood vessels. It is characterized by necrotic inflamma-
tion of blood vessels, leading to thinning of the vessel walls and
capillaries. The cause of onset of vasculitis is still somewhat
unclear. However, it has been shown to occur as a result of infec-
tion, medication toxicity, cancer, or as a complication in RA and
SLE patients.
Neutrophils play a role in the generation of the autoantibodies
that result in the development of ANCA-associated systemic
vasculitis. This subgroup of vasculitis is defined by the presence
of autoantibodies generated against the neutrophil granule pro-
teins PR3 and MPO (Niles et al., 1989). These autoantigens also
induce NETosis in primed neutrophils and were found to be
localized to DNA within the NET structures. Typical components
of NETs such as DNA/histone complexes have been identified in
the glomeruli and interstitium of kidney biopsies taken from
vasculitis patients, revealing (like in SLE) that they may be
involved in the development of glomerulonephritis. There is
also a strong link to plasmacytoid dendritic cell activation by
these autoantigen complexes and the release of IFN-a around
the site of kidney damage (Kessenbrock et al., 2009).
Autoimmunity and Infection
While it is well documented that patients suffering from autoim-
mune diseases are more prone to infections that contribute toCell Host & Microbethe morbidity and mortality of the dis-
eases, the link between autoimmune
onset and infection is less clear.
Investigations into infections and RA
onset have not been fruitful to date. A
study in Sweden revealed a high preva-
lence (45%) of prior infection in patients
diagnosed with all forms of inflammatory
arthritis. This screen examined many
pathogens, including Chlamydia tracho-
matis and pneumonia, Campylobacter
jejuni, Borrelia burgdorferi, parvovirus
B19, and Salmonella Typhimurium. While
C. jejuni was the most prevalent infection
prior to onset, this was only clear in
patients with reactive arthritis disease(So¨derlin et al., 2003). As reviewed by Carty et al. (2003), while
many infectious agents have been shown to be present prior
to infection, there is no clear consensus that this is a causing
factor of RA.
Pathogens utilizemolecules similar to host molecules to evade
the immune system, and as such in molecular mimicry, the
immune response can eventually turn toward the self peptide
as a result of cross-reactivity with subsequent activation of
naive, autoreactive T cells. This can be responsible for initiation
of autoimmune diseases such as SLE (Radic and Marion, 2013).
While neutrophils are central to host defense against pathogen
attack, they are also clearly involved in the progression of
autoimmunity. As many molecules found in neutrophils have
been proven to be antigens in autoimmune diseases, methods
to target these cells early in the onset of disease may provide
a mechanism to prevent or dampen autoimmune disease
progression.
Conclusion
Neutrophils are considered the front line of host defense against
pathogen attack, as they are the first immune cells to arrive at the
site of infection and are equipped with an arsenal of weapons to
ensure successful clearance of pathogens. The importance of
neutrophils in antimicrobial defense has been outlined here by
the sheer numbers of new neutrophils generated on a daily basis
to ensure the numbers required to clear infection are always
available. This has been further confirmed by the fact that indi-
viduals with mutations in proteins important for neutrophil func-
tion or neutropenic patients succumb to certain infections more
readily than healthy people. However, one must be aware that
even though neutrophils aim to be helpful in the immune
response, as they will do anything to ensure death of pathogens,
this can also result in the release of potentially harmful self mol-
ecules that are known to be antigens in the progression of an
autoimmune disease (Figure 3). Therefore, while it is clear that
neutrophils are important in host defense, they must also be15, May 14, 2014 ª2014 Elsevier Inc. 533
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Reviewthought of as potentially dangerous to the host and as a potential
therapeutic target in autoimmunity.
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